biologit
Sarah Jane Devaney currently serves as the Head of Pharmacovigilance & Quality Assurance at biologit since November 2023. Previously, Sarah held various positions at Eli Lilly and Company from July 2021 to October 2023, including Manager in CMC Development Regulatory. With extensive experience in pharmacovigilance, Sarah has also worked at Acorn Regulatory Consultancy Services Limited as Team Lead and deputy QPPV, and at Eurofins Lancaster Laboratories as a Microbiology Analyst Contractor. Sarah's educational background includes multiple certificates in Quality Management, Regulatory Affairs, and BioPharmaChem from Technological University of the Shannon, along with a Master’s Degree in Microbiology and a Bachelor's Degree in Applied Biosciences.
This person is not in any teams
This person is not in any offices
biologit
Biologit delivers advanced active safety surveillance solutions for the life sciences sector, addressing human and veterinary pharmacovigilance, cosmetovigilance, nutravigilance, and materiovigilance. Biologit MLM-AI is a state-of-the-art platform for monitoring scientific literature to identify adverse events and emerging risks throughout a product's lifecycle, from clinical development to post-marketing. Designed for teams of all sizes, it combines a flexible workflow with a unified global and local scientific database, enhanced by unique AI-driven screening and productivity tools. These features enable fast, accurate, and fully traceable results for all safety surveillance needs. Biologit Database is a robust, continuously updated repository of scientific literature, optimised for compliant regulatory searches. It integrates global and regional sources into an intuitive interface, delivering high-quality results for monitoring adverse events and potential risks. With over 65 million entries and 40,000 new articles added daily from 120,000 journals across 170+ countries, it ensures comprehensive coverage aligned with FDA, EMA GVP and global standards. Biologit provides a full suite of pharmacovigilance services, including Qualified Person for Pharmacovigilance (QPPV) and Responsible Person for Pharmacovigilance (RPPV) support in clinical trials.